09:33 AM EST, 02/04/2025 (MT Newswires) -- Supernus Pharmaceuticals ( SUPN ) said Tuesday that the US Food and Drug Administration has approved its Onapgo injection to treat motor fluctuations in adults with advanced Parkinson's disease.

The biopharmaceutical company said Onapgo will be available in Q2.

Shares of Supernus Pharmaceuticals ( SUPN ) were up more than 4% in early trading.